Rx Medicare

Despite government warnings and professional recommendations about diabetes risks associated with second-generation antipsychotic drugs, fewer than one-third of Medicaid patients who are treated with these medications undergo tests of blood glucose or lipid levels, according to a report in the January issue of Archives of General Psychiatry, one of the JAMA/Archives journals…

Read More…

Related Posts

• Pediatricians Warn Payment System May Force Them To Stop Accepting Medicaid Patients
• Investigation: Washington State Moves Medicaid Nursing Home Patients To Adult Family Homes
• Bellevue Natural-Birth Center In NYC Closes; Catered To Immigrants, Medicaid Patients
• New Medicare Policy May Pose Risks To Black Kidney Patients
• Florida Medicaid HMO Patients Informed Of Right To Leave Plans For ‘Good Cause’ Reasons
• Disparity In Cataract Surgery: Medicare Patients 5.5 Times More Likely To Get Surgery Than VA Patients
• Senate Test Vote Today On Bill To Extend COBRA Subsidy, Doc Fix And State Medicaid Funding
• Medical ID Thefts Can Harm Patients’ Health; Prosecutors Go After Medicare Fraud
• South Carolina, Oklahoma And Arkansas Grapple With Medicaid Cuts To Help Balance Budget
• Federal Court Rejects California Medicaid Cuts
• Jobs Bill Missing Medicaid Money For States, Governors Call For Change
• Recession Swells Medicaid Rolls, Shrinks State Treasuries
• Florida Faces Fight Over Medicaid Reform Expansion; In Kansas, Cuts Hurt A Mental Health Clinic
• Huge Medicaid Cuts To Occur If Congress Fails To Extend Enhanced Federal Funding
• Louisiana, Oklahoma, Mich., Arizona Plan Medicaid Cuts; N.C.’s Prison Health Costs

Tags: antipsychotics, easing, medicaid, metabolic, patients, risks, unmonitored

This entry was posted on Wednesday, January 6th, 2010 at 5:01 pm and is filed under Uncategorized. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.